RET-IN-21

RET-IN-21 (compound 5) is a selective RETV804M inhibitor with the IC50 of 0.02 μM. RET-IN-21 does not inhibit the wild type isoforms of RET or KDR. RET-IN-21 has antitumor activity[1].

Product Specifications

CAS Number

[2414373-42-3]

UNSPSC

12352005

Target

RET

Type

Reference compound

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/ret-in-21.html

Purity

97.00

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

O=C(N)C1=CC=C(C2=C3N=C(NCC4=CC=NC=C4)C=CN3N=C2)C=C1

Molecular Formula

C19H16N6O

Molecular Weight

344.37

References & Citations

[1]Newton R, et al. Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RETV804M Kinase. ACS Med Chem Lett. 2020 Feb 28;11 (4) :497-505.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, protect from light)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

148565 100 µg

SV2A, Control Peptide (Synaptic Vesicle Glycoprotein 2a, Synaptic Vesicle Protein 2a, SV2, KIAA0736, PSEC0174)

Ask

View Details

LY411870 100 µg

BRUNOL5 (CELF5) (NM_021938) Human Over-expression Lysate

Ask

View Details

HY-P81661-01 10 µL

NONO Antibody (YA1406, Rabbit)

Ask

View Details

HY-P81661-02 50 μL

NONO Antibody (YA1406, Rabbit)

Ask

View Details

HY-P81661-03 100 µL

NONO Antibody (YA1406, Rabbit)

Ask

View Details

NBP2-73889AF532 0.1 mL

Mouse Monoclonal RhoD Antibody (OTI2F7) [Alexa Fluor 532]

Ask

View Details